<DOC>
	<DOCNO>NCT00290836</DOCNO>
	<brief_summary>The overall objective compare efficacy safety TachoComb H versus standard surgical treatment control local bleeding patient undergo prostatectomy . Specific objective include comparison test treatment intraoperative haemostatic efficacy well post-operative blood loss assess haemoglobin haematocrit concentration drainage fluid .</brief_summary>
	<brief_title>Assess Efficacy Safety TachoComb H vs. Standard Surgical Treatment ( i.e . Suturing ) Patients Undergoing Prostatectomy ( TC-017-AU )</brief_title>
	<detailed_description />
	<mesh_term>Thrombin</mesh_term>
	<mesh_term>Aprotinin</mesh_term>
	<criteria>1. subject give informed consent accord local requirement trial related activies ? A trial related activity procedure would perform routine management subject . 2 . Is subject 18 year age ? 3 . Is subject planned radical prostatectomy prostate cancer ( cT3 ) ? After prostate resection primary haemostatic treatment 4. minor ( i.e . ooze ) moderate haemorrhage persist primary surgical haemostatic procedure major vessel ( pulsate arterial haemorrhage and/or major venous bleed ) ? Exclusion : At preoperative screen 1 . Is anamnestic laboratory evidence coagulation disorder include haemophilia A B von Willebrand disease ? 2 . Has patient history allergic reaction application human fibrinogen , human thrombin , bovine aprotinin and/or collagen origin ? 3 . Is patient undergoing emergency operation ? 4 . Did patient participate clinical trial le 30 day prior inclusion present trial ? 5 . Does patient participate clinical trial concomitantly present trial ? After tumour resection primary haemostatic treatment 6 . Has serious surgical complication occur ? 7 . Has fibrin glue haemostatic ( include type TachoComb ) use randomisation ?</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>May 2012</verification_date>
</DOC>